Related Experiment Video
Updated: Jun 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region
Ali Bazarbachi1, Hamdy A Azim, Hussain Alizadeh
1Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. bazarbac@aub.edu.lb
Abstract:
In the Middle East and North Africa (MENA) region, cancer has many epidemiologic and clinical features that are different from those in the rest of the world. Additionally, the region has a relatively young population and large disparities in the availability of resources at diagnostic and treatment levels. A critical need exists for regional guidelines on cancer care, including those for lymphoid malignancies. A panel of lymphoma experts from MENA reviewed the 2009 version of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Non-Hodgkin's Lymphoma and Hodgkin Lymphoma and suggested modifications for the region that were discussed with the United States NCCN Lymphoma Panels. This article presents the consensus recommendations.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
